Chargement en cours...
GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia
Hypermethylation of GPX3 (glutathione peroxidase 3) promoter has been identified in various solid tumors. However, the pattern of GPX3 promoter methylation in acute myeloid leukemia (AML) remains unknown. The current study was intended to investigate the clinical significance of GPX3 promoter methyl...
Enregistré dans:
| Publié dans: | Am J Cancer Res |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529623/ https://ncbi.nlm.nih.gov/pubmed/26269763 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|